The UBC Mood Disorders Centre is now recruiting for a new clinical trial that is examining the efficacy of adjunctive cannabidiol (CBD) in treating bipolar depression.
The research team is looking for individuals who are diagnosed with bipolar disorder type I or II, currently taking a mood stabilizer and/or atypical antipsychotic and are currently experiencing a depressive episode.
Participants visit the clinic for a screening visit and a baseline visit, as well as visits at weeks 2, 4, and 6 to complete clinical assessments with a study doctor, laboratory tests, and answer questionnaires. Eligible participants will receive either a placebo or 200-600mg of CBD to take daily for 6 weeks.
If you have any patients who are interested in participating, please contact the research coordinator at bipolar.research@ubc.ca or 604-822-8045.